All In Biotech

Drug Trial Radar · NCT05115136

Using Doxepin for Urticaria

The Use of Doxepin for Urticaria in the Emergency Department

Last checked: Nov 19, 2026Latest source record: May 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

160

Planned (sponsor's estimate)

Start

May 23, 2022

Primary completion

Jan 31, 2023

Study completion Jul 1, 2023

Sponsor

Lead sponsor
State University of New York - Upstate Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 10, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Isolated urticaria in the emergency department is widely treated by physicians with histamine blocking agents such as diphenhydramine, cetirizine, and cimetidine. Doxepin is a tricyclic antidepressant that has been shown to have much higher concentrations of histamine blocking activity and therefore may be useful in treating urticaria. The purpose of this study is to compare the effectiveness of using doxepin verses a traditional medication, diphenhydramine (Benadryl), in the treatment of isolated urticaria in the emergency department.

Conditions

  • Urticaria

Interventions

  • DoxepinDrug

    25mg dose of Doxepin will be administered one time, by mouth

  • DiphenhydramineDrug

    50 mg dose of Diphenhydramine will be administered one time, by mouth

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement of urticariaTime frame: 1 hour after med administration, 2 hours after administration, and prior to discharge.
  2. Improvement of urticariaTime frame: 1 hour after med administration, 2 hours after administration, and prior to discharge

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • SUNY Upstate Medical University

    Syracuse, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.